QS Investors’s Genomic Health, Inc. GHDX Stock Holding History

QS Investors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-45,400	Closed	-$3.08M	–	1687
2019 Q3	$3.08M	Hold	45,400	–	–	0.03%	415
2019 Q2	$2.64M	Buy	45,400 +19,880	+78%	+$1.18M	0.03%	488
2019 Q1	$1.79M	Buy	25,520 +25,320	+12,660%	+$1.88M	0.02%	647
2018 Q4	$13K	Buy	+200	New	+$14K	﹤0.01%	1495

QS Investors's GHDX Position: Q4 2019 in Review

QS Investors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 45,400 shares — an estimated $3.08M sold.

QS Investors first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $3.08M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

QS Investors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
QS Investors sold 45,400 Genomic Health, Inc. shares in Q4 2019, an estimated $3.08M.
QS Investors first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
QS Investors's Genomic Health, Inc. position peaked at $3.08M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on QS Investors's 13F filing for Q4 2019, filed 14 Feb 2020.